loader
Please Wait
Applying Filters...

Evonik Evonik

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Certificates of Suitability (CEPs) for r1_cep_2011_214___rev_00 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

    Client Virtual Booth
    Menu

    WUXI JIDA PHARMACEUTICAL CO LTD

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    PharmaCompass

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 WUXI JIDA PHARMACEUTICAL CO., LTD. Jiangyin CN (1)

    filter

    01 Citalopram hydrobromide (1)

    filter

    01 China (1)

    filter

    01 Valid (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    WUXI JIDA PHARMACEUTICAL CO., LTD. ...

    Contact Supplier
      Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
      Post an Enquiry Post an Enquiry
      Flag China
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      Citalopram hydrobromide

      PDF Supplier PDF
      URL Supplier Web Content
      R1-CEP 2011-214 - Rev 00
      Valid
      Chemical
      2017-09-14
      2288
      ASK
      US
      PHARMACOMPASS
      Upload
      your Marketing & Sales content

      Looking for Certificates of Suitability (CEPs) for R1-CEP 2011-214 - Rev 00 of Wuxi Jida Pharmaceutical Co., Ltd. Jiangyin Cn

      Looking for Certificates of Suitability (CEPs) for R1-CEP 2011-214 - Rev 00 of Wuxi Jida Pharmaceutical Co., Ltd. Jiangyin Cn 1

      20

      Wuxi Jida Pharmaceutical Co., Ltd. Jiangyin Cn, based in China, is a pharmaceutical company.

      One of their significant offerings is Citalopram hydrobromide, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2011-214 - Rev 00

      This Chemical Type CEP, issued on September 14, 2017, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.

      Substance Number 2288 associated with this CEP further emphasizes

      Post Enquiry
      POST ENQUIRY